SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about outcome of rights issue committee meeting

27 Apr 2016 Evaluate

Sun Pharma Advanced Research Company has informed that the Right Issue Committee of Director, authorized by board of directors, at its meeting on April 27, 2016 from 10:00 am to 10:30 am, has approved the allotment of 10,204,081 fully paid-up equity shares of face value of Re 1 each at a price of Rs. 245 per equity share (including a share premium of Rs 244 per equity share) issued on a Right basis, to all eligible applicants who have subscribed to the said issue and whose applications were valid.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

147.90 -4.25 (-2.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×